Shlevin Harold H.

DirectorGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Dec 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$172K
Net Open-Market Flow
-$172K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2025Option exercise(M)20K$1.98$40K31K
Dec 17, 2025Sell(S)5K$7.04$33K7K
Dec 17, 2025Sell(S)20K$7.04$139K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 17, 2025Option exercise(M)20K$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-25-000067) within minutes of acceptance. Every field above traces to the original document. Verify it directly: